Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers.
about
Risk factors assessment and risk prediction models in lung cancer screening candidatesEvaluation of lymph node metastasis in lung cancer: who is the chief justice?Advancing biomedical imagingFrom diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules, a summary of the 2015 Chinese-German Lung Cancer Expert PanelThe use of a smartphone application for fast lung cancer risk assessment†.Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practiceMicroRNA as tools and therapeutics in lung cancerMicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival.Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1.Screening and Biosensor-Based Approaches for Lung Cancer Detection.Recent insights into human bronchial proteomics - how are we progressing and what is next?Serum and blood based biomarkers for lung cancer screening: a systematic review.Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
P2860
Q26747819-2BB60BCF-FA07-4DB4-85BA-C6A4A460368CQ26774986-7496087C-434E-48B3-8DDA-DF70B11FF824Q26776383-74CAF524-6BD6-4EF1-9FA2-EC0A76BDA128Q28066842-1B517CAD-3129-4814-A766-9F2D9EDED962Q33452704-A1DF5046-AEAA-4C71-896C-8F05ECB53C11Q33908633-304E1DB6-0AD6-4356-9738-1621D0E0BE7CQ35738706-0C22E059-1638-4268-B891-318C7B73873AQ36890487-E5465F74-8B4E-40CC-93B2-5CAA5BFC6BCCQ37374550-7AFA369E-4B43-46DB-BB17-953BA157EC0FQ37580040-549F700A-BE8D-42BE-A193-91847C692AD8Q37694872-A5BCFDC8-595A-43DB-99E9-AB640BCFA608Q47182931-FFBC9E04-0B2F-4C2F-804C-067758E87B64Q47271963-40241937-C074-4951-9582-B4C45494FFD1Q50033192-399EFA63-B9BB-4572-961F-15FB7B4CA6E1Q58591218-0E4FAE08-4DDF-4B7B-83D5-54B27CEFA7CC
P2860
Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers.
@en
type
label
Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers.
@en
prefLabel
Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers.
@en
P2093
P2860
P1433
P1476
Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers.
@en
P2093
Mani S Kavuru
Naveed Hasan
Rohit Kumar
P2860
P2888
P304
P356
10.1007/S00408-014-9636-Z
P577
2014-08-10T00:00:00Z
P5875
P6179
1038072522